If you have Type 1 diabetes and questions about GLP-1 therapy, insulin adjustments, or weight management strategies, were here to provide thoughtful, evidence-based guidance tailored to your situation
The longer acting GLP-1 receptor agonists are more effective than the shorter acting forms at reducing HbA 1c and fasting glucose levels, whereas the shorter acting forms are more effective at reducing postprandial glucose levels [3]
In most cases, methylcobalamin is nontoxic, even in large doses
discontinue immediately if rash, persistent itching, or breathing changes appear
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review